|
ZNF571 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36480002246964E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.0513000449115E-09 |
| Normal-vs-Stage2 |
5.195200E-04 |
| Normal-vs-Stage3 |
2.95585778076202E-12 |
| Normal-vs-Stage4 |
1.21730000524067E-08 |
| Stage1-vs-Stage2 |
3.006000E-02 |
| Stage1-vs-Stage3 |
5.588100E-02 |
| Stage1-vs-Stage4 |
3.923000E-01 |
| Stage2-vs-Stage3 |
2.715100E-03 |
| Stage2-vs-Stage4 |
2.347700E-02 |
| Stage3-vs-Stage4 |
5.868000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.72599950893004E-10 |
| Normal-vs-AfricanAmerican |
8.232000E-04 |
| Normal-vs-Asian |
2.12950000000323E-06 |
| Caucasian-vs-AfricanAmerican |
2.715800E-01 |
| Caucasian-vs-Asian |
1.034160E-01 |
| AfricanAmerican-vs-Asian |
9.479800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27420000106682E-08 |
| Normal-vs-Female |
8.45460035314716E-10 |
| Male-vs-Female |
7.704200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.26889998508517E-09 |
| Normal-vs-Age(41-60Yrs) |
1.59530166854438E-11 |
| Normal-vs-Age(61-80Yrs) |
1.22779999500722E-08 |
| Normal-vs-Age(81-100Yrs) |
2.656500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.148200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.415600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.261600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.282400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.225400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.088000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.50901999999009E-05 |
| Classical-VS-Follicular |
5.925900E-02 |
| Classical-VS-Other |
6.865200E-01 |
| Classical-VS-Normal |
1.63440000422455E-08 |
| Tall-VS-Follicular |
3.63640000000665E-07 |
| Tall-VS-Other |
5.960100E-03 |
| Tall-VS-Normal |
2.84772205816353E-13 |
| Follicular-VS-Other |
7.908000E-01 |
| Follicular-VS-Normal |
2.11529999999405E-05 |
| Other-VS-Normal |
3.344100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.60329560528317E-11 |
| Normal-vs-N1 |
4.89420004523566E-09 |
| N0-vs-N1 |
1.930950E-01 |
|
|
